Published in Am J Ophthalmol on January 01, 2003
Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev (2010) 2.70
Human cytomegalovirus resistance to antiviral drugs. Antimicrob Agents Chemother (2005) 1.83
New reporter cell line to evaluate the sequential emergence of multiple human cytomegalovirus mutations during in vitro drug exposure. Antimicrob Agents Chemother (2005) 0.86
Cytomegalovirus retinitis successfully treated with ganciclovir implant in a patient with blood ganciclovir resistance and ocular ganciclovir sensitivity. Eye (Lond) (2012) 0.82
Late emergence of A594V and L595W mutations related to ganciclovir resistance in a patient with HCMV retinitis and long-term HIV progression. Braz J Med Biol Res (2015) 0.75
How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients. Blood (2016) 0.75
Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med (2011) 19.42
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology (2012) 11.91
Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol (2008) 3.14
Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A (2002) 2.94
Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology (2013) 2.82
Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci (2011) 2.53
A mobile phone-based retinal camera for portable wide field imaging. Br J Ophthalmol (2013) 2.24
Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol (2002) 2.20
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology (2012) 2.19
Utility of intraoperative optical coherence tomography during vitrectomy surgery for vitreomacular traction syndrome. Retina (2014) 2.15
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database Syst Rev (2014) 1.95
Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann Neurol (2003) 1.93
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol (2010) 1.82
Imaging pulsatile retinal blood flow in human eye. J Biomed Opt (2008) 1.73
Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology (2012) 1.70
Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol (2009) 1.64
Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes. Diabetologia (2014) 1.59
Uveitis-associated flap edema and lamellar interface fluid collection after LASIK. Am J Ophthalmol (2005) 1.57
Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. Ophthalmology (2013) 1.57
Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema. Retina (2010) 1.56
Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology (2013) 1.52
Trends in the etiology of infectious corneal ulcers at the F. I. Proctor Foundation. Cornea (2004) 1.48
Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol (2011) 1.46
Sutureless 23-gauge versus 20-gauge vitrectomy with silicone oil injection in rhegmatogenous retinal detachment. Retina (2012) 1.46
Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Invest Ophthalmol Vis Sci (2011) 1.46
Chronic recurrent varicella-zoster virus keratitis confirmed by polymerase chain reaction testing. Am J Ophthalmol (2005) 1.42
Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am J Ophthalmol (2007) 1.42
ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency. Virol J (2006) 1.41
Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts. J Virol (2006) 1.39
Pathological findings in eyes with the ganciclovir implant. Ophthalmology (2005) 1.38
Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology (2012) 1.32
A5-positive primary sensory neurons are nonpermissive for productive infection with herpes simplex virus 1 in vitro. J Virol (2011) 1.30
Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient. Am J Ophthalmol (2005) 1.27
Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Am J Ophthalmol (2007) 1.26
Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells. Retina (2006) 1.25
Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology (2005) 1.22
Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice. Diabetes (2006) 1.19
Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci (2010) 1.17
Ocular changes after photodynamic therapy. Invest Ophthalmol Vis Sci (2006) 1.17
Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci (2006) 1.16
Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation. Arch Ophthalmol (2009) 1.13
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression. Ophthalmology (2004) 1.13
Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia. J Virol (2007) 1.13
A novel segmentation algorithm for volumetric analysis of macular hole boundaries identified with optical coherence tomography. Invest Ophthalmol Vis Sci (2013) 1.13
Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis. Ophthalmology (2004) 1.11
Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction. Mol Cell Endocrinol (2012) 1.10
Ranibizumab. Nat Rev Drug Discov (2006) 1.08
Trypan blue: effect on retinal pigment epithelial and neurosensory retinal cells. Invest Ophthalmol Vis Sci (2005) 1.07
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment. Ophthalmology (2004) 1.07
Three cases of large retinal capillary hemangiomas treated with verteporfin and photodynamic therapy. Arch Ophthalmol (2005) 1.06
Wet age-related macular degeneration. Adv Drug Deliv Rev (2005) 1.06
Accuracy and reliability of telemedicine for diagnosis of cytomegalovirus retinitis. Am J Ophthalmol (2011) 1.06
Uncertain compassion in using a drug before the risks and benefits are known. Arch Ophthalmol (2006) 1.05
Epidemiology of ulcerative keratitis in Northern California. Arch Ophthalmol (2010) 1.04
Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000). Am J Ophthalmol (2008) 1.02
Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin). Retina (2009) 0.99
Intracorneal graphite particles. Cornea (2004) 0.99
Assessment of the differences in pharmacokinetics and pharmacodynamics between four distinct formulations of triamcinolone acetonide. Retina (2013) 0.97
Mitochondrial DNA variants mediate energy production and expression levels for CFH, C3 and EFEMP1 genes: implications for age-related macular degeneration. PLoS One (2013) 0.96
''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases. J Mol Diagn (2007) 0.96
The clinical differentiation of bacterial and fungal keratitis: a photographic survey. Invest Ophthalmol Vis Sci (2012) 0.95
Intravitreous dexamethasone effects on different patterns of diabetic macular edema. Arch Ophthalmol (2010) 0.95
Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion/traction. Retina (2015) 0.95
Does asymptomatic shedding of herpes simplex virus on the ocular surface lead to false-positive diagnostic PCR results? Br J Ophthalmol (2008) 0.94
Novel mutations in the CHST6 gene associated with macular corneal dystrophy in southern India. Arch Ophthalmol (2003) 0.94
Metaplastic squamous epithelial downgrowth after clear corneal cataract surgery. Am J Ophthalmol (2006) 0.94
VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT). JAMA Ophthalmol (2014) 0.92
Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients. Clin Ophthalmol (2010) 0.92
Efficacy of anti-vascular endothelial growth factor therapy in subretinal neovascularization secondary to macular telangiectasia type 2. Retina (2012) 0.92
Rose bengal and lissamine green inhibit detection of herpes simplex virus by PCR. Am J Ophthalmol (2006) 0.92
Tissue-specific splicing of the herpes simplex virus type 1 latency-associated transcript (LAT) intron in LAT transgenic mice. J Virol (2006) 0.91
Mitochondrial DNA damage induced by 7-ketocholesterol in human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci (2009) 0.90
Cigarette smoking as a risk factor for uveitis. Ophthalmology (2009) 0.90
Pegaptanib sodium. Nat Rev Drug Discov (2005) 0.90
Novel mutations in the carbohydrate sulfotransferase gene (CHST6) in American patients with macular corneal dystrophy. Am J Ophthalmol (2004) 0.90
Intraocular sustained-release delivery systems for triamcinolone acetonide. Pharm Res (2009) 0.90
Expression pattern of 12-lipoxygenase in human islets with type 1 diabetes and type 2 diabetes. J Clin Endocrinol Metab (2014) 0.89
Investigation of the mechanism by which herpes simplex virus type 1 LAT sequences modulate preferential establishment of latent infection in mouse trigeminal ganglia. J Virol (2009) 0.89
Effects of Benzo(e)Pyrene, a toxic component of cigarette smoke, on human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci (2008) 0.89
Caspase-8, -12, and -3 activation by 7-ketocholesterol in retinal neurosensory cells. Invest Ophthalmol Vis Sci (2007) 0.89
Ocular complications of smallpox vaccination. Am J Ophthalmol (2003) 0.89
Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial. Arch Ophthalmol (2008) 0.89
Epstein-barr infection of the retina: case report and review of the literature. Retin Cases Brief Rep (2011) 0.88
Diagnosis and management of herpetic anterior uveitis. Int Ophthalmol Clin (2002) 0.88
Treatment of conjunctival squamous cell carcinoma with topical cidofovir. Am J Ophthalmol (2002) 0.88
Insulin-like growth factor I increases alpha Vbeta 3 affinity by increasing the amount of integrin-associated protein that is associated with non-raft domains of the cellular membrane. J Biol Chem (2001) 0.87
Human herpesvirus 6-A, 6-B, and 7 in vitreous fluid samples. J Med Virol (2010) 0.87
Effects of enzymatic sterilization detergents on the corneal endothelium. Arch Ophthalmol (2002) 0.86
Access to ophthalmologic care in Thailand: a regional analysis. Ophthalmic Epidemiol (2013) 0.86
Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins. J Med Chem (2013) 0.86
A new mutation (Leu569Arg) within exon 13 of the TGFBI (BIGH3) gene causes lattice corneal dystrophy type I. Am J Ophthalmol (2003) 0.86
Optical coherence tomography in progressive outer retinal necrosis. Ophthalmic Surg Lasers Imaging (2006) 0.86
Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis. Ophthalmology (2006) 0.85
The Implantable Miniature Telescope for macular degeneration. Curr Opin Ophthalmol (2006) 0.85